PremieBreathe

Target SDGs

Market Suggested Retail Price

$350.00

Target Users (Target Impact Group)

Small and Medium-sized Enterprises, Public Sector Agencies

Distributors / Implementing Organizations

Unknown

Competitive Landscape

Direct competitors include Neovent, FREO2-SIPHON, and Pumani Bubble Continuous Positive Airway Pressure (bCPAP) Device.

Countries

Ethiopia, Malawi, Rwanda

Manufacturing/Building Method

This product is currently in the prototyping phase and not yet manufactured at scale. Prototypes are being developed at Yale University in Prof. Gonzalez's lab. 

Intellectural Property Type

Select Type

User Provision Model

The designers have not yet selected their user provision model.

Distributions to Date Status

None - product still in prototype stage

Design Specifications

PremieBreathe, is a humidified high flow nasal cannula (HHFNC) device that delivers variable flows of warmed, humidified, and oxygenated air to provide respiratory support for premature and newborn infants.  The device incorporates an ultraviolet water sterilization mechanism to kill waterborne bacteria. It also incorporates reusable, biofouling-­resistant tubing rather than the disposable circuit used in the commercial technology, embodied by a mobile, compact housing, designed to incorporate a rechargeable battery source, ensures that our device can provide portable oxygen therapy for critically ill newborns in need of undisrupted support, while in transport between hospitals and health centers.

Technical Support

Provided by the manufacturers

Replacement Components

Replacement components include flow regulators and humidification bottles.

Lifecycle

Unknown

Manufacturer Specified Performance Parameters

The maufacturers set out to develop a low-cost respirator that can safely provide warmed, humidified and blended oxygen to neonates in need.

Vetted Performance Status

Pilot tests were performed in Ethiopia at Ayder Referral Hospital to establish the performance and functional parameters after about a half-a-dozen prototyping iterations.

Safety

The manufacturers have taken steps to test the device in a clinical environment to ensure its safety.

Complementary Technical Systems

Unknown

Academic Research and References

Compliance with regulations

None

Other Information

None